| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 20, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter fiscal 2006 on Thursday, April 27, 2006 at approximately 8:30 a.m. (ET). The...
-
Apr 11, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that its shareholder Rights Agreement expired on April 10, 2006. The Company said there were no plans to renew it. The Perrigo...
-
Mar 21, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market terconazole vaginal...
-
Mar 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) invites the public to access a webcast of Chairman, President and CEO, Dave Gibbons' presentation at the Bank of America 2006 Consumer Conference on...
-
Mar 7, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Ciclopirox Olamine Cream USP,...
-
Mar 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Chief Financial Officer Douglas R. Schrank will retire from his post on June 30, 2006. Judy L. Brown, Senior Vice President and...
-
Feb 22, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, through a partnership with InvaGen Pharmaceuticals, it has received tentative approval from the U.S. Food and Drug...
-
Feb 21, 2006Authorizes Extension of Share Repurchase Program
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced the appointment by the Board of Directors of Ran Gottfried as a new director of the Company. Mr. Gottfried was appointed to serve for...
-
Feb 15, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on March 21, 2006 to shareholders of record...
-
Feb 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter (OTC) nicotine polarcrilex...